URL | https://endpts.com/vor-bio-opts-to-keep-manufactur |
Source | ENDPOINTS NEWS |
Date Published | 09/29/2022 |
Author Name | Tyler Patchen |
Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
Company/Division name | Vor Biopharma |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Year reshoring announced: | 2022 |
City reshored to: | Cambridge |
State(s) reshored to: | MA |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | hematopoietic stem cells (eHSCs), CAR-T therapies |
What domestic positive factors made reshoring more attractive? | Skilled workforce availability/training |